ABBOTT LABORATORIES

87.41 $ -0.41%

Add to a list

Valuation: Abbott Laboratories

Capitalization 152B 131B 120B 113B 210B 14,551B 214B 1,425B 556B 6,964B 571B 559B 24,227B P/E ratio 2026 *
22x
P/E ratio 2027 * 18.8x
Enterprise value 164B 141B 129B 122B 227B 15,680B 230B 1,535B 599B 7,505B 616B 603B 26,108B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 2.94x
Free-Float
86.73%
Yield 2026 *
2.83%
Yield 2027 * 3.01%
1 day-0.41%
1 week+3.48%
Current month-3.72%
1 month-4.08%
3 months-23.71%
6 months-31.28%
Current year-30.23%
1 week 86.83
Extreme 86.83
89.34
1 month 81.97
Extreme 81.97
94.79
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5d. change 1-year change 3-years change Capi.($)
-0.41%+3.48%-33.43%-15.98% 152B
+0.58%+3.22%-2.58%-10.16% 101B
+0.17%-5.32%+45.27%+60.06% 55.13B
+3.57%+6.67%-5.97%+60.71% 53.49B
+0.94%+2.90%-13.86%-39.80% 40.68B
-0.24%+2.27% - - 31.3B
+0.28%+16.99%-14.68%-38.23% 27.82B
+0.09%+4.47%+53.91%-7.11% 22.35B
-2.53%+2.39%-13.99%+12.24% 22.19B
-1.41%+2.10%-10.88%+7.83% 21.24B
Average +0.10%+6.03%+0.42%+3.28% 52.74B
Weighted average by Cap. +0.28%+4.19%-7.02%+1.40%

Financials

2026 *2027 *
Net sales 50.3B 43.36B 39.52B 37.42B 69.5B 4,807B 70.56B 471B 184B 2,301B 189B 185B 8,004B 54.82B 47.26B 43.07B 40.79B 75.74B 5,239B 76.9B 513B 200B 2,508B 206B 201B 8,723B
Net income 7.02B 6.05B 5.51B 5.22B 9.7B 671B 9.85B 65.69B 25.64B 321B 26.34B 25.78B 1,117B 8.17B 7.04B 6.42B 6.08B 11.29B 781B 11.46B 76.44B 29.84B 374B 30.65B 30B 1,300B
Net Debt 11.82B 10.19B 9.29B 8.79B 16.33B 1,129B 16.58B 111B 43.17B 541B 44.35B 43.41B 1,881B 8.71B 7.51B 6.85B 6.48B 12.04B 833B 12.23B 81.56B 31.83B 399B 32.7B 32.01B 1,387B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-05-22 87.41 $ -0.41% 9.52M
26-05-21 87.77 $ -0.69% 8.52M
26-05-20 88.38 $ -0.50% 7.83M
26-05-19 88.82 $ +1.04% 11.69M
26-05-18 87.91 $ +4.07% 12.35M
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
87.41USD
Average target price
118.64USD
Spread / Average Target
+35.73%

Quarterly revenue - Rate of surprise